Frederick Financial Consultants’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Sell
2,338
-228
-9% -$49.1K 0.25% 55
2026
Q1
$558K Sell
2,566
-94
-4% -$20.9K 0.28% 56
2025
Q4
$608K Sell
2,660
-49
-2% -$11.2K 0.33% 50
2025
Q3
$627K Buy
2,709
+68
+3% +$13.8K 0.35% 46
2025
Q2
$490K Buy
2,641
+120
+5% +$22.3K 0.3% 53
2025
Q1
$528K Buy
2,521
+667
+36% +$130K 0.38% 49
2024
Q4
$329K Buy
+1,854
New +$341K 0.26% 56

Other funds holding ABBV

Frederick Financial Consultants's ABBV Position: Q2 2026 in Review

Frederick Financial Consultants reduced its AbbVie (ABBV) stake by 8.9% in Q2 2026, selling an estimated $49.1K and leaving 2,338 shares worth $588K. The position accounts for 0.25% of the portfolio, ranked #55.

Frederick Financial Consultants first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $627K in Q3 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Frederick Financial Consultants held 2,338 shares of AbbVie worth $588K as of Q2 2026.
  • Frederick Financial Consultants sold 228 AbbVie shares in Q2 2026, an estimated $49.1K.
  • AbbVie made up 0.25% of Frederick Financial Consultants's portfolio in Q2 2026, its #55 holding.
  • Frederick Financial Consultants first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Frederick Financial Consultants's AbbVie position peaked at $627K in Q3 2025.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Frederick Financial Consultants's 13F filing for Q2 2026, filed 14 Aug 2026.